Ipca Laboratories (IPCALAB) Share Price Fall Streak: 2nd Straight Session Lower

Ipca Laboratories Share Price Fall Streak is extending in its second straight session, with the latest traded price at Rs 1,799 and a cumulative decline of 5.92% across the run from Rs 1,912.20. According to latest Univest figures, the price event is confirmed, but no company-specific catalyst is established. The share price fall leaves Ipca Laboratories Share Price Fall Streak as a clear event-led read for investors tracking the stock today.

Ipca Laboratories Share Price Fall Streak matters because the move now spans more than one session, so readers can view it as a pattern rather than a single intraday slip. The company’s market capitalisation stands at Rs 46,592.78 crore, which places Ipca Laboratories Share Price Fall Streak in the large-cap bracket. For a reader, that backdrop helps distinguish a consecutive decline from a one-off market move in the stock.

Ipca Laboratories (IPCALAB) Share Price Fall Streak: Consecutive Decline Analysis

Metric	Value
Current Price	Rs 1,799
Previous Close	Rs 1,836.5
Today's Move	-Rs 37.50 (-2.04%)
Open	Rs 1,830.05
High	Rs 1,852.8
Low	Rs 1,799
Market Capitalisation	Rs 46,592.78 crore

Ipca Laboratories Share Price Fall Streak opened the session at Rs 1,830.05, touched a high of Rs 1,852.80 and a low of Rs 1,799, with the latest traded price at the day’s low. Compared with the previous close of Rs 1,836.50, the stock was down Rs 37.50 or 2.04% at the timestamp used for this article. The market capitalisation of Rs 46,592.78 crore keeps Ipca Laboratories Share Price Fall Streak within the large-cap category, which is important context when comparing the move with peers and the broader healthcare set.

The range shows that Ipca Laboratories Share Price Fall Streak traded below the open through the latest print, and the gap between the day high and the latest traded price was Rs 53.80. Because this is the second straight session of decline, the two-session pattern is now more relevant than the one-day move alone. For readers following Ipca Laboratories Share Price Fall Streak, the key point is that the price stayed near the lower end of the range while the session was still open, which keeps the focus on the continuing downside pattern rather than an isolated swing.

What the Consecutive Declines Show

Ipca Laboratories Share Price Fall Streak has now moved lower in a second straight session, and that changes the reading of the stock from a single-day fall to a short streak. The cumulative decline of 5.92% from the streak start price of Rs 1,912.20 gives a broader view of the move than the latest session alone. That cumulative figure is the key reference point for Ipca Laboratories Share Price Fall Streak today.

For investors, the streak framing matters because the latest traded price sits well below the starting level of the run, even before any end-of-day view is taken. The latest session’s 2.04% decline is smaller than the full two-session drop, so the streak itself remains the main story. Univest figures confirm the price action, but they do not point to a specific company trigger. That keeps Ipca Laboratories Share Price Fall Streak squarely in the category of a verified market move without a stated trigger.

Ipca Laboratories (IPCALAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 46,592.78 crore
P/E Ratio	35.57x
P/B Ratio	5.49x
ROE	15.88%
ROCE	19.41%
EPS	Rs 51.63
Book Value Per Share	Rs 334.38
Dividend Yield	0.33%

Ipca Laboratories (IPCALAB) fundamental metrics show P/E 35.57x, P/B 5.49x, ROE 15.88%, ROCE 19.41%. Taken on their own, these numbers offer context rather than a trading signal.

Ipca Laboratories has a market capitalisation of Rs 46,592.78 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 35.57x, P/B at 5.49x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.88% and ROCE of 19.41%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 51.63, book value per share of Rs 334.38, dividend yield of 0.33%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.95x, median ROE of 10.96%, median ROCE of 13.01%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	35.57x
Benchmark Median P/E	30.95x
Benchmark Average P/E	46.82x
Benchmark P/E Range	3.1x to 629.67x
Company P/B Ratio	5.49x
Benchmark Median P/B	2.82x
Benchmark Average P/B	4.18x
Company ROE	15.88%
Benchmark Median ROE	10.96%
Benchmark Average ROE	9.51%
Company ROCE	19.41%
Benchmark Median ROCE	13.01%
Benchmark Average ROCE	12.48%
Company Market Capitalisation	Rs 46,592.78 crore
Benchmark Median Market Cap	Rs 720.23 crore
Benchmark Average Market Cap	Rs 13,282.41 crore

Ipca Laboratories (IPCALAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Ipca Laboratories (IPCALAB) has a P/E ratio of 35.57x, which is above the benchmark median of 30.95x, a difference of +14.93%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Ipca Laboratories (IPCALAB) has a ROE of 15.88%, which is above the benchmark median of 10.96%, a difference of +44.89%. Ipca Laboratories (IPCALAB) has a ROCE of 19.41%, which is above the benchmark median of 13.01%, a difference of +49.19%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,22,282.95	34.91	4.88	14.85	19.11
Divi's Laboratories	DIVISLAB	2,44,762.03	83.68	13.86	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,73,447.74	79.53	19.32	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,12,149.36	24.85	4.16	19.69	21.39
Laurus Labs	LAURUSLABS	1,11,250.29	101.75	19.73	18.31	18.2

Ipca Laboratories (IPCALAB) has a P/E ratio of 35.57x compared with the displayed peer median of 79.53x. The comparison is relative and should not be read as a recommendation. Its ROE of 15.88% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 19.41% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Ipca Laboratories (IPCALAB) has a market capitalisation of Rs 46,592.78 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Ipca Laboratories

• Ipca Laboratories Share Price Fall Streak has now extended into a second straight session, so the move is no longer a one-day event.
• The latest traded price of Rs 1,799 sits below the previous close of Rs 1,836.50 and near the day low, which keeps price action in focus.
• The cumulative decline of 5.92% from Rs 1,912.20 gives the streak a wider lens than the latest session alone.
• P/E of 35.57 and P/B of 5.49 remain above the same-industry median readings, so valuation stays relevant even after the drop.
• ROE of 15.88% and ROCE of 19.41% keep the operating-return profile part of the read on Ipca Laboratories Share Price Fall Streak.

About Ipca Laboratories

Ipca Laboratories works in Healthcare and the Pharmaceuticals & Drugs industry. For readers tracking Ipca Laboratories Share Price Fall Streak, the useful context is that the company operates in a sector where valuation and return metrics vary widely across peers. The business profile matters here because the streak is being read against a large-cap pharmaceutical company with earnings, book value and profitability measures that remain visible in the latest figures.

The company’s place in the sector is best understood through its market capitalisation, return ratios and peer set rather than through a short-term share price move alone. That is the right lens for Ipca Laboratories Share Price Fall Streak, because the streak shows market pricing behaviour while the company description explains what kind of business sits underneath that price.

Track Ipca Laboratories Share Price on Univest

Use Ipca Laboratories (IPCALAB) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Track Ipca Laboratories Share Price Fall Streak on Univest for the latest share price, key valuation ratios, 52-week levels and market insights in one place. Readers can follow Ipca Laboratories Share Price Fall Streak alongside fundamentals, sector context and peer metrics without leaving the stock page.

Frequently Asked Questions

What is Ipca Laboratories Share Price Fall Streak today?

Ans. Ipca Laboratories Share Price Fall Streak is in its second straight session of decline. The latest traded price is Rs 1,799, which is below the previous close of Rs 1,836.50 and keeps the streak in focus today.

How much has Ipca Laboratories Share Price Fall Streak moved across the two sessions?

Ans. Ipca Laboratories Share Price Fall Streak is down 5.92% across the run from Rs 1,912.20. That cumulative move is the clearest way to read the streak, because it captures both sessions rather than only the latest one.

What was the latest session move in Ipca Laboratories Share Price Fall Streak?

Ans. In the latest session, Ipca Laboratories Share Price Fall Streak was down Rs 37.50 or 2.04% versus the previous close. The stock opened at Rs 1,830.05 and traded between Rs 1,852.80 and Rs 1,799 during the period covered.

What is the market capitalisation of Ipca Laboratories Share Price Fall Streak?

Ans. Ipca Laboratories Share Price Fall Streak has a market capitalisation of Rs 46,592.78 crore. That places the company in the large-cap category and gives context to the recent decline versus the broader healthcare peer set.

How does Ipca Laboratories Share Price Fall Streak compare on valuation?

Ans. Ipca Laboratories Share Price Fall Streak trades at a P/E of 35.57 and a P/B of 5.49. The P/E is above the industry median of 30.95, while the P/B is also above the median of 2.82.

What do ROE and ROCE show for Ipca Laboratories Share Price Fall Streak?

Ans. ROE stands at 15.88% and ROCE at 19.41% for Ipca Laboratories Share Price Fall Streak. Both readings are above the benchmark medians in the same-industry set, which adds useful context to the valuation discussion.

What does EPS and book value say about Ipca Laboratories Share Price Fall Streak?

Ans. EPS is Rs 51.63 and book value is Rs 334.38 for Ipca Laboratories Share Price Fall Streak. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.

Does dividend yield matter for Ipca Laboratories Share Price Fall Streak?

Ans. Dividend yield is 0.33% for Ipca Laboratories Share Price Fall Streak. It gives a payout context relative to the current price, but the current story remains centered on the two-session decline and valuation metrics.

Should investors track Ipca Laboratories Share Price Fall Streak next?

Ans. Investors can track Ipca Laboratories Share Price Fall Streak for further price behaviour, valuation changes and sector comparison. The current data confirms the streak, but it does not establish a company-specific catalyst for the move.